InvestLog
INDV Indivior Pharmaceuticals Inc logo

INDV Indivior Pharmaceuticals Inc

Healthcare
$37.53+0.19%ClosedMarket Cap: $4.68B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

18.15

PEG

0.03

P/B

-32.67

P/S

3.63

EV/EBITDA

11.10

DCF Value

$2.65

FCF Yield

-3.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

83.1%

Operating Margin

33.3%

Net Margin

19.4%

ROE

-142.0%

ROA

21.0%

ROIC

85.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$317.0M$89.0M$—
Q4 null$358.0M$102.0M$—
FY null$1.24B$210.0M$—
Q3 null$314.0M$42.0M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$44.67

Target (Median)

$48.00

Target Range

$36.00 - $50.00

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-01-12
Piper SandlerOverweight
2025-10-31
HC Wainwright & Co.Buy
2025-10-30
Craig-HallumBuy
2025-08-27
Craig-HallumBuy
2025-06-30

Trading Activity

Insider Trades

View All
Wheadon David E.director
SellThu May 14
Thompson Julietdirector
SellThu May 14
Thompson Julietdirector
SellThu May 14
Stejbach Markdirector
SellThu May 14
Ryan Barbaradirector
SellThu May 14

Related AI Research

8-K EventMay 4, 2026

INDV files 8-K — Item 7.01 Regulation FD

Indivior Pharmaceuticals Inc.

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

—

Beta

1.20

Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

Peers

ACAD logoACADADMA logoADMAAMRX logoAMRXCRNX logoCRNXHNGE logoHNGELNTH logoLNTHOPCH logoOPCHPRAX logoPRAXSUPN logoSUPNVKTX logoVKTX